Pharmacokinetics of Once-Daily DTG/3TC FDC in Children Living With HIV: D3/PENTA21 Sub-Study
Background: There is an increasing emphasis on reducing toxicity and improving acceptability of HIV-treatment. Two-drug regimens, consisting of two different antiretroviral drug classes, are recommended as an alternative to standard three-drug regimens, with dolutegravir and lamivudine (DTG/3TC) included in a number of adult treatment guidelines. This nested pharmacokinetics (PK) sub-study within the D3/Penta21 randomized controlled…